Andrew Mazar

Biography

 Dr. Mazar serves as the Entrepreneur-in-Residence and the Director, Center for Developmental Therapeutics (CDT) within the Chemistry of Life Processes Institute at Northwestern University.  Prior to joining Northwestern University, Dr. Mazar was the Chief Scientific Officer at Attenuon, LLC in San Diego and led discovery and development efforts resulting in three drugs entering oncology clinical trials. Dr. Mazar is the Chair of the NCI Nano Alliance Animal Model working group and a member of the NHLBI Scientific Review Board (SRB) for the SMARTT program, serves as Associate Editor for Recent Patent Reviews on Anti – Cancer Drug Discovery and is a member of the editorial board of Clinical Cancer Research.  He is also the co-author of 99 peer reviewed publications and 16 reviews and book chapters.  Dr. Mazar has founded or advised several start-up companies over the past 5 years and has been involved in raising >$120M in investment and partnership capital for these entities. 

Research Interest

 Dr. Mazar serves as the Entrepreneur-in-Residence and the Director, Center for Developmental Therapeutics (CDT) within the Chemistry of Life Processes Institute at Northwestern University.  Prior to joining Northwestern University, Dr. Mazar was the Chief Scientific Officer at Attenuon, LLC in San Diego and led discovery and development efforts resulting in three drugs entering oncology clinical trials. Dr. Mazar is the Chair of the NCI Nano Alliance Animal Model working group and a member of the NHLBI Scientific Review Board (SRB) for the SMARTT program, serves as Associate Editor for Recent Patent Reviews on Anti – Cancer Drug Discovery and is a member of the editorial board of Clinical Cancer Research.  He is also the co-author of 99 peer reviewed publications and 16 reviews and book chapters.  Dr. Mazar has founded or advised several start-up companies over the past 5 years and has been involved in raising >$120M in investment and partnership capital for these entities.